Several studies suggest that PPARγ is protective, as mice lacking PPARγ in the heart developed cardiac hypertrophy and dysfunction [26,27] and treatment with a PPARγ agonist reduced cardiac remodeling and fibrosis in a rat model of hypertension [27]. This evidence concerns the gene PPARG and hypertensive disorder.